| 1. |
Name:
|
Liliana Bachs, M.D. |
| 2. |
Title: |
Senior Medical Officer, Divisions of Forensic Toxicology and Drug Abuse, Norwegian Institute of Public Health
|
| 3. |
Medical Marijuana
Position: |
Con
to the question "Should marijuana be a medical option?"
|
| 4. |
Reasoning: |
"About marijuana as a medical option, I do not think that marijuana has more advantages than other therapies, taking the side effects into consideration. So the answer is no."
(12/1/05 email to ProCon.org) |
| 5. |
Credibility
Ranking: |
Key Experts
Physicians [We believe physicians are the "key experts" in the medical marijuana debate because the issue is thought by many to be ultimately based on the medical value and risks of marijuana, and Physicians, with their training and clinical work, should (at least in theory) have the best knowledge of marijuana's medical value and risks.].
|
| 6. |
Involvement: |
- Senior Medical Officer, Divisions of Forensic Toxicology and Drug Abuse, Norwegian Institute of Public Health
|
| 7. |
Education: |
- M.D., Universitat Autonoma de Barcelona, Spain
- Specialty in clinical pharmacology, Oslo, Norway
|
| 8. |
Relevant Affiliations/Honors: |
- 2000 - The International Association of Forensic Toxicologists award for "Best Poster Presentation in Helsinki"
|
| 9. |
Contact Info: |
|
| 10. |
Other: |
- 8/26/05, Presented "Blood Concentrations of Codeine, Morphine and Morphine-glucuronide: Relationship With Degree of Impairment" at International Council on Alcohol, Drugs and Traffic Safety
- 2004 - Co-author "Deaths After Intravenous Misuse of Transdermal Fentanyl," Journal of Forensic Sciences, (2004; 49 (6))
- L. Bachs, S. Skurtveit, J. Mørland. "Codeine and Clinical Impairment in Samples in Which Morphine is Not Detected," European Journal of Clinical Pharmacology (2003 Apr; 58(12):785-9)
|
.org